Paola Armaroli obtained Medical Degree, specialization in Hygiene and Preventive Medicine, School of Public Health, and a MSc in Epidemiology in the University of Turin, Italy. Since 2003 she is working in CPO-Piedmont, involved in several national and international independent epidemiological studies and trials on cancer screening. Member of the working groups on “EU cervical cancer screening guideline- supplements on HPV testing and HPV vaccination”, “European Code Against Cancer”, “European guidelines for Quality Assurance of Colorectal Cancer Screening”, in collaboration with the International Agency for Research on Cancer (IARC) (Lyon, France) and founded by the European Commission

Paola Armaroli obtained Medical Degree, specialization in Hygiene and Preventive Medicine, School of Public Health, and a MSc in Epidemiology in the University of Turin, Italy. Since 2003 she is working in CPO-Piedmont, involved in several national and international independent epidemiological studies and trials on cancer screening. Member of the working groups on “EU cervical cancer screening guideline- supplements on HPV testing and HPV vaccination”, “European Code Against Cancer”, “European guidelines for Quality Assurance of Colorectal Cancer Screening”, in collaboration with the International Agency for Research on Cancer (IARC) (Lyon, France) and founded by the European Commission

Cristina is a third-year PhD student with a master’s in public health, working at the Epidemiology and Evaluation Department of Hospital del Mar and the Hospital del Mar Research Institute in Barcelona, Spain. As a nurse working in colorectal cancer screening, her research focuses on developing communication strategies to support informed decision-making in the context of risk-based screening. She employs qualitative and participatory methodologies to engage the target population, promoting understanding of these strategies within the mental models of risk approach. Through her work in the Screening Program, Cristina aims to bridge research and practice, further promoting evidence-based cancer prevention.

He obtained the MSc in Molecular Biology in 1994 and Ph.D. in Cellular and Animal Biology in 1998 at the University of Pavia (Pavia, Italy). Now he is the director of the Epidemiology Service in the Local Health Authority – IRCCS in Reggio Emilia. His principal interest is the evaluation of Public Health interventions; the fields in which he is involved are cancer prevention (screening and primary) and infectious diseases (in particular HTA of the new vaccines).He is a member of the Guidelines Development Group for the European Commission Initiative on Breast, Cervical and Colorectal Cancer.

I hold a PhD in psychiatric genetics from the University of Copenhagen and Lundbeck. Since then, my focus has shifted to leveraging genetic information and registry data to enhance our understanding of cancer, as well as integrating these data sources to improve cancer risk prediction, which has significant implications for areas such as screening programs.

Gian Paolo Morgano is a research methodologist. His research focuses on guideline development and decision-thresholds. He currently serves for the European Commission (EC) Joint Research Centre (JRC), where he coordinates the development of the European Breast Cancer and Colorectal Cancer Guidelines on Screening and Diagnosis. Gian Paolo holds a PhD in Health Research Methodology from McMaster University, where he was appointed as a part-time assistant professor. Gian Paolo has co-authored more than 50 scientific articles.

A/Prof Nickson is an epidemiologist specialising in the evaluation of cancer screening, diagnosis and treatment. She heads the Breast Cancer Policy and Evaluation stream at the Daffodil Centre and led the Breast ROSA project. Her other research activities include clinical and health economics modelling of breast cancer control strategies, piloting risk-based approaches to breast cancer screening, and health service evaluation and technology assessments. A/Prof Nickson works closely with clinicians, health service program managers and policy makers.

MD MSc Coordinator of the Piedmont Region Cancer Screening program. Experience in design, implementation and analysis of RCTs evaluating screening strategies, diagnostic technologies, and primary prevention interventions, in the development of clinical guidelines and implementation of quality control projects of cancer care. PI of comparative effectiveness studies of different screening strategies, of RCTs evaluating new technologies and fecal and blood biomarkers as potential screening tools. Invited specialist: IARC Handbooks (Vol. 17 – CRC Screening; Preamble to the IARC Handbooks of Cancer Prevention) Member: experts working group of the European Commission Initiative on Colorectal Cancer. Co-chair: ICSN CRC working group.